Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the clinical and microbiological efficacy and safety
of NVC-422 compared to vehicle for adenoviral conjunctivitis. Adults and children one year of
age and older with diagnosis of adenoviral conjunctivitis in at least one eye based upon a
positive adenovirus test result using the Aden-Detactor Plus kit (Rapid Pathogen Screening,
Inc).
Subjects will be randomly assigned to receive either NVC-422 or Vehicle.